Connor, Clark & Lunn Investment Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 20,511 shares of REGN stock, worth $15.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
20,511
Previous 9,503 115.84%
Holding current value
$15.2 Million
Previous $9.99 Million 115.89%
% of portfolio
0.11%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$1024.09 - $1201.76 $11.3 Million - $13.2 Million
11,008 Added 115.84%
20,511 $21.6 Million
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $6.63 Million - $8.04 Million
7,502 Added 374.91%
9,503 $9.99 Million
Q1 2024

May 09, 2024
SELL
$902.69 - $993.35 $166,997 - $183,769
-185 Reduced 8.46%
2,001 $1.93 Million
Q4 2023

Feb 09, 2024
SELL
$775.18 - $881.7 $372,086 - $423,216
-480 Reduced 18.0%
2,186 $1.92 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $9.89 Million - $12.1 Million
-14,287 Reduced 84.27%
2,666 $2.19 Million
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $8.98 Million - $10.7 Million
-12,834 Reduced 43.09%
16,953 $12.2 Million
Q1 2023

May 09, 2023
BUY
$680.49 - $826.97 $7.88 Million - $9.58 Million
11,581 Added 63.61%
29,787 $24.5 Million
Q4 2022

Feb 10, 2023
BUY
$705.89 - $766.39 $9.86 Million - $10.7 Million
13,972 Added 330.0%
18,206 $13.1 Million
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $634,810 - $801,097
1,106 Added 35.36%
4,234 $2.92 Million
Q2 2022

Aug 05, 2022
SELL
$548.35 - $738.84 $2.85 Million - $3.84 Million
-5,204 Reduced 62.46%
3,128 $1.85 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $5.6 Million - $6.57 Million
-9,407 Reduced 53.03%
8,332 $5.82 Million
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $3.2 Million - $3.94 Million
5,879 Added 49.57%
17,739 $11.2 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $7.53 Million - $8.94 Million
-13,124 Reduced 52.53%
11,860 $7.18 Million
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $475,636 - $561,891
-1,006 Reduced 3.87%
24,984 $14 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $7.9 Million - $9.7 Million
17,687 Added 213.02%
25,990 $12.3 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $547,653 - $696,137
1,145 Added 16.0%
8,303 $4.01 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $1.26 Million - $1.52 Million
2,310 Added 47.65%
7,158 $4.01 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $452,867 - $591,118
918 Added 23.36%
4,848 $3.02 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $5.4 Million - $7.95 Million
-16,070 Reduced 80.35%
3,930 $1.92 Million
Q4 2019

Feb 12, 2020
BUY
$274.13 - $376.51 $4.02 Million - $5.53 Million
14,675 Added 275.59%
20,000 $7.51 Million
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $3.34 Million - $3.89 Million
-12,225 Reduced 69.66%
5,325 $1.48 Million
Q2 2019

Aug 07, 2019
BUY
$299.6 - $414.82 $3.94 Million - $5.45 Million
13,150 Added 298.86%
17,550 $5.49 Million
Q1 2019

May 08, 2019
BUY
$372.08 - $439.57 $586,026 - $692,322
1,575 Added 55.75%
4,400 $1.81 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $545,707 - $654,940
-1,625 Reduced 36.52%
2,825 $1.06 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $219,462 - $255,318
625 Added 16.34%
4,450 $1.8 Million
Q2 2018

Aug 02, 2018
SELL
$284.6 - $344.99 $113,840 - $137,996
-400 Reduced 9.47%
3,825 $1.32 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $228,969 - $285,490
-725 Reduced 14.65%
4,225 $1.46 Million
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $8,965 - $11,748
25 Added 0.51%
4,950 $1.86 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $269,612 - $315,000
625 Added 14.53%
4,925 $2.2 Million
Q2 2017

Aug 14, 2017
BUY
N/A
4,300
4,300 $2.11 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email